+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Host immunological status modification by various chemotherapeutic drugs



Host immunological status modification by various chemotherapeutic drugs



Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(11): 1450-1452



There are many unsolved problems about the effects on a host's cellular immunologic status by various chemotherapeutics used routinely. Thus, we performed an experimental study mainly on these effects using mouse effector cells. We administered the usual therapeutic dosage of various chemotherapeutic agents to 8-week female C57BL/6 mice, and 3 days after these administrations all mice were sacrificed and splenectomised. The number of splenocytes in whole spleen, LAK precursor cell activity, NK cell activity, and IL-2 productivity were determined, and these results were compared with those for normal mice. Although CY, 5-FU, MMC and LIB exhibited immunologic depressive effects, BLM and PEP showed augmentative effects, and ADR and CDDP no effects. It seemed important that the appropriate drug selection be made on the basis of the above data in order to be the best therapeutic regimen for the individual patient's malignancy.

(PDF emailed within 1 workday: $29.90)

Accession: 046274839

Download citation: RISBibTeXText

PMID: 8373203


Related references

Role of immunological processes for the therapeutic effect of chemotherapeutic drugs. Schweiz Zeitschr Path U Bakt 13(3): 353-358, 1950

Cutaneous reactions to chemotherapeutic drugs and targeted therapies for cancer: part I. Conventional chemotherapeutic drugs. Journal of the American Academy of Dermatology 71(2): 203.E1-203.E12; Quiz 215-6, 2014

Modification of the antitumor activity of chemotherapeutic drugs by the hypoxic cytotoxic agent tirapazamine. Cancer ChemoTherapy and Pharmacology 39(4): 361-366, 1997

The present status of the chemotherapeutic drugs. Journal of Pharmacy and Pharmacology 6(10): 673-693, 1954

The effects of chemotherapeutic drugs (OXA and 5-FU) on the expression of immunological related molecules in the human colorectal cancer cells. 2007

The Present Status of Chemotherapeutic and Antibiotic Drugs. Postgraduate Medical Journal 27(310): 376-376, 1951

Studies on nutritional and immunological status in active pulmonary tuberculosis. 2. Investigation of the alterations of nutritional and immunological parameters on treatment with antituberculous drugs. Journal of Nara Medical Association 38(5): 833-841, 1988

Trypanosoma cruzi: immunological consequences of parasite modification of host cells. Clinical and Experimental Immunology 40(1): 36-41, 1980

Modification of host response abstract mouse immunological tolerance neo natal thymectomy. British Medical Journal 5539: 560-561, 1967

Endogenous immunity and antibiotic therapy. Studies on the influence of host-specific defense mechanism on the antimicrobial effect of chemotherapeutic drugs in vitro. Fortschritte der Medizin 89(27): 1054, 1971

Modification of rpmi 1640 for use in in vitro immunological studies of host parasite interactions in giardiasis. Journal of Clinical Microbiology 29(3): 627-629, 1991

Release of prostaglandin d 2 and thromboxane b 2 from human thrombocytes radio immunological determination and modification by drugs. Naunyn-Schmiedeberg's Archives of Pharmacology 302(SUPPL): R27, 1978

Studies on chemotherapeutic drugs against viruses. V. Chemotherapeutic effect of sodium 3-phenyl-azonaphthionate on neurotropic virus. Keio med. J, Tokyo, 1: 49-54, 1952

Correlations between the changes in developmental course of swine Strongyloides and the immunological status of the host. Procnt. Congr. Parasit. (Rome 21-26: 841-843., 1966